BioPharma Credit (LSE:BPCR) Financial Strength : 8 (As of Dec. 2022)

BioPharma Credit Financial Strength Calculation

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

BioPharma Credit's Interest Expense for the months ended in Dec. 2022 was $0.0 Mil. Its Operating Income for the months ended in Dec. 2022 was $0.0 Mil. And its Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2022 was $0.0 Mil.

BioPharma Credit's Interest Coverage for the quarter that ended in Dec. 2022 is

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

BioPharma Credit PLC has no debt.

2. Debt to revenue ratio. The lower, the better.

BioPharma Credit's Debt to Revenue Ratio for the quarter that ended in Dec. 2022 is

3. Altman Z-Score.

Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

The zones of discrimination were as such:

When Z-Score is less than 1.81, it is in Distress Zones.
When Z-Score is greater than 2.99, it is in Safe Zones.
When Z-Score is between 1.81 and 2.99, it is in Grey Zones.

Altman Z-Score does not apply to banks and insurance companies.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioPharma Credit  (LSE:BPCR) Financial Strength Explanation

The maximum rank is 10. Companies with rank 7 or higher will be unlikely to fall into distressed situations. Companies with rank of 3 or less are likely in financial distress.

BioPharma Credit has the Financial Strength Rank of 8. It shows strong financial strength and is unlikely to fall into distressed situations.

BioPharma Credit Financial Strength Related Terms

Thank you for viewing the detailed overview of BioPharma Credit's Financial Strength provided by GuruFocus.com. Please click on the following links to see related term pages.

BioPharma Credit (LSE:BPCR) Business Description